Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Seladelpar safe, effective for primary biliary cholangitis
10 Apr 2022
In patients with primary biliary cholangitis, the use of seladelpar, a selective peroxisome proliferator-activated receptor-delta agonist, safely improves biochemical markers of cholestasis and inflammation, reports a new study.
Seladelpar safe, effective for primary biliary cholangitis
10 Apr 2022
Hepatitis B virus treatment rates still low among eligible patients
10 Apr 2022
Administration rates of antiviral therapy remain low among treatment-eligible patients with chronic hepatitis B virus (CHB) and among CHB patients without human immunodeficiency virus (HIV), reveals a recent study.
Hepatitis B virus treatment rates still low among eligible patients
10 Apr 2022
CRP thresholds inform success of dexamethasone, tocilizumab against COVID-19 mortality
10 Apr 2022
Using C-reactive protein (CRP) levels as indicators for early treatment with tocilizumab and dexamethasone can help reduce mortality in hospitalized patients with the coronavirus disease 2019 (COVID-19), a recent study has found.






